8.62
8.62 (0%)
As of Apr 17, 2025
Theravance Biopharma, Inc. [TBPH]
Source:
Company Overview
Theravance Biopharma, Inc. is a biopharmaceutical company primarily focused on the development and commercialization of medicines.
| Country | United States |
| Headquarters | george town, grand cayman |
| Phone Number | 650-808-6000 |
| Industry | manufacturing |
| CEO | Rick E Winningham |
| Website | www.theravance.com |
Financial Year:
Financial Overview (Dollars in Millions)
| Revenue | $64.4 |
| Operating Profit | $-46.9 |
| Net Income | $-56.4 |
| Net Cash | $-1.7 |
Profit Ratios
| Gross Margin | $64.4 |
| Operating Margin | -72.9 |
| Profit as % of Revenues | -114.1% |
| Profit as % of Assets | -15.3% |
| Profit as % of Stockholder Equity | -32.1% |
Management Effectiveness
| Return on Equity | -32.1% |
| Return on Assets | -15.9% |
| Turnover Ratio | 17.5% |
| EBITA | $-46.9 |
Balance Sheet and Cash Flow Measures
| Total Assets | $354.2 |
| Total Liabilities | $178.6 |
| Operating Cash Flow | $-11.5 |
| Investing Cash Flow | $12.3 |
| Financing Cash Flow | $-2.5 |
